Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
53 participants
INTERVENTIONAL
2015-06-01
2016-12-10
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Periodized Aerobic Interval Training in Metabolic Syndrome
NCT03119493
The Effects of High-intensity Aerobic Training in Patients With Metabolic Syndrome
NCT02130336
Exercise in Prevention of Metabolic Syndrome
NCT01676870
Exercise Training on Health and Medical Costs of Metabolic Syndrome Individuals.
NCT05120778
Resistance Training and Metabolic Syndrome
NCT02918448
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
intervention
Aerobic interval training
Aerobic interval training
Carried out 3 times per week for 16 weeks
Control group
The participants performed only initial evaluation and at the end of the study
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Aerobic interval training
Carried out 3 times per week for 16 weeks
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Age between 35 - 60 years and untrained subjects.
Exclusion Criteria
* Chronic pulmonary diseases
* Neurological disorders
* Kidney failure
* High-risk cardiovascular diseases (Unstable angina pectoris, Uncompensated heart failure, complex ventricular arrhythmias or myocardial infarction during the last month).
35 Years
60 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Universidade Estadual Paulista Júlio de Mesquita Filho
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Rodolfo Augusto Travagin Miranda
Mr. Rodolfo Augusto Travagin Miranda
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Rodolfo AT Miranda, Me
Role: PRINCIPAL_INVESTIGATOR
Universidade Estadual Paulista Júlio de Mesquita
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
RATMiranda1
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.